Rhinophyma

Rhinophyma begins as rosacea — chronic inflammation of the skin that causes redness from vascular dilation and formation. It carries hereditary components, and social/environmental risk factors including frequent alcohol use, caffeine, and ultraviolet light exposure are associated with progression, though alcohol use alone does not cause rhinophyma — a common misconception. There also appears to be an association with a skin mite, Demodex folliculorum, which favors the oil glands of hypervascular skin and can drive further inflammation and scarring of nasal tissue over time.

Rhinophyma is diagnosed clinically, based on its characteristic appearance of redness, visible surface vessels, and skin thickening, though a biopsy is occasionally used to confirm the diagnosis or rule out other conditions in cases that don't respond as expected to initial treatment.

The condition is most common in men between roughly 50 and 70, particularly those with fair skin and Northern European or Celtic ancestry, and a family history of rosacea. Left untreated, rhinophyma does not resolve on its own — it's a progressive condition that typically worsens over time, leading to more pronounced thickening and shape change, and, once it reaches sufficient size, can begin to affect nasal airway breathing function as well.

• Persistent redness or visible vessels on the nose that haven't responded to typical rosacea skincare
• Thickening, bumpy, or irregular texture developing on the nasal skin
• A sense that the nose is gradually enlarging or changing shape over months to years
• Nasal breathing that feels more obstructed than it used to

Mild, earlier-stage rhinophyma is often manageable with medication alone, so there's no need to wait until the condition is advanced to be evaluated — in fact, earlier evaluation is what keeps medical management a realistic option for longer, rather than surgery becoming the only path forward.

Initial management of milder rhinophyma involves medication, including antibiotics, metronidazole, and oral isotretinoin — the latter prescribed by a doctor and monitored closely given its significant side-effect profile. These options can meaningfully slow or manage early-stage disease, but they don't reverse tissue that has already thickened significantly.

Advanced rhinophyma requires surgical treatment to remove the excess tissue. Several techniques exist — including CO2 or Erbium laser ablation, electrosurgery, dermabrasion, and cold-steel excision — and in most advanced cases, direct surgical removal of the thickened skin is the most effective method. Treatment is typically done under sedation rather than general anesthesia, with the procedure itself generally taking between thirty minutes and two hours depending on severity; more extensive cases occasionally benefit from a second, staged procedure to reach the best final result.

Immediately after surgical treatment, the nose will appear raw and exposed, with a tendency to bleed and crust for roughly the first eight to ten days. Meticulous wound care — copious ointment coverage while new skin develops — is important during this window to reduce the risk of infection or scarring. Most patients don't report significant pain, but plan to stay largely indoors during this early period while caring for the wound site.

Redness typically continues to fade over the following two to three weeks, with the final result — smoother, more proportionate nasal skin — continuing to develop over two to three months as healing completes. Occasionally, additional treatment is recommended after sufficient recovery to further refine the outcome, which may involve another round of surgical excision, dermabrasion, or laser resurfacing.